International Stem Cell Corp. (ISCO) to Share Parkinson’s Disease Program Data at Society for Neuroscience Annual Meeting
International Stem Cell Corp., a California-based biotechnology company developing novel stem cell based therapies, today told investors that it will be presenting preliminary data from its IND-enabling study in Parkinson's disease at the Society for Neuroscience annual meeting in San Diego, CA, on November 10th 2013. The Society for Neuroscience is the world's largest organization of scientists and clinicians dedicated to understanding the brain and nervous system. Over 30,000 attendees are expected at this year’s annual meeting, making it one of the largest scientific and medical conferences in the world. ISCO's Parkinson's disease program uses human parthenogenetic neural stem cells…